Dr. Rath Research Institute

Millions of Americans taking statin medications to lower their cholesterol appear to be at a higher risk of type 2 diabetes, a new study suggests. The study found a nearly 50 percent increase in diabetes among longtime statin users, throwing cold water on the idea of prescribing the drugs to healthy people to prevent heart disease.

{Comments: This is not the first time that statins are linked to diabetes. Repeatedly for last 3-4 years, there are multiple studies confirming this association that people taking statin drugs to lower cholesterol are at a higher risk of developing diabetes. With this analysis by the Woman’s Health Initiative (WHI), statins increase the risk of diabetes in postmenopausal women by 48%.

Diabetes is known to cause complications in many other organs, including coronary arterial blockages leading to heart attacks, kidney and eye damage and poor wound healing. All these are attributable to poor circulation to the respective organs. Type II diabetes is growing to pandemic proportions due to obesity, a sedentary lifestyle and several other factors, and now pharmaceutical drugs further contribute to the diabetic patient pool. The cost of diabetes treatment alone is $218 billion. This combined with heart disease increase the costs to $618 billion for the US alone. Interestingly, the anti-diabetic drugs Avandia and Actos came under scrutiny for increasing the risk of heart disease, and statins, while trying to decrease the risk of heart disease, can cause diabetes. Yet, this is unlikely to affect the use of statins which are becoming “the most successful drugs of all times.” A few years ago statins were approved for children, and recently approval has been extended to people who do not yet have high cholesterol, but may fall into a vague category of “high risk for heart disease.” The use of statin drugs has become so extensive that these drugs might as well be put in the water as some doctors suggest sarcastically.

People spend hundreds of dollars monthly to stay on stain therapy and the drug makers earn billions in profit from statins. Yet, patients do not have any satisfactory solution to their problem. Mounting evidence proves the safety and efficacy of nutrients in controlling several aspects of heart disease, diabetes and many other chronic diseases. However, nutrients cannot be covered under patent protection and therefore drug companies are not interested in promoting them. Instead, pharmaceutical companies prefer to generate more business opportunities by spending their resources on marketing synthetic drugs that are harmful and could complicate the diseases.

Dr. Rath's groundbreaking discovery that "cholesterol is not the cause but a symptom of already existing heart disease," explains that the deficiency of specific nutrients, especially vitamin C and the amino acid lysine is the root cause of heart disease. Studies show that lowering cholesterol levels using medications does not reduce the incidence of heart disease, but causes several other problems including cancer. Please read more about these facts with detailed explanations of the importance of nutrients in Dr. Rath's book "Why People Get Heart Attacks But Animals Don’t!" and the results of various clinical trials using nutrient supplementation in chronic diseases at www.drrathresearch.org}

Source: http://www.sci-tech-today.com/story.xhtml?story_id=022000GRL72W